Gastric Bypass Surgery (RYGB) Can Give A Better Control Of Type 2 Diabetes And Obesity
Even though it is possible to lower the body weight and high blood sugar (glucose) levels by participating in an intensive lifestyle modification program, it is difficult to stick to these measures for a longer period. The following options are available for a severely obese patient with a poorly controlled diabetes to lower the blood sugar (glucose) levels.
The current guidelines suggest a Bariatric surgery for a weight loss for a patient with a body mass index (BMI) of over 40 kg/m2 or for patient with an obesity-associated diseases such as type 2 diabetes (T2D) with a body mass index (BMI) over 35 kg/m2.
An earlier study shows a reversal of type 2 diabetes with a Bariatric surgery in an obese patient having a high blood sugar (glucose) levels. But some healthcare professionals hesitate to recommend a Bariatric surgery to a mild overweight to the morbidly obese patient with type 2 diabetes.
But this trial shows patients with an uncontrolled (or a poorly controlled) blood glucose levels and with mild obesity can be benefited from the Bariatric surgery.
A three year randomized controlled trial SLIMM-T2D (Surgery or Lifestyle with Intensive Medical Management in the Treatment of Type 2 Diabetes) study has found that a 58 percent of the patients who underwent a bypass surgery called Roux-en-Y gastric bypass (RYGB) surgery has achieved better A1C levels of less than seven percent when compared to a 11 percent of patients who underwent the Weight Achievement and Intensive Treatment (Why WAIT) program from the Joslin Diabetes Center. Other improvements are.
Researchers have conducted a randomized study on 38 obese patients with type 2 diabetes (15 men and 23 women), aged between 46 and 58 years with a body mass index between 33 kg/m2 and 44 kg/m2. Researchers have randomly selected 19 patients to the laparoscopic Roux-en-Y gastric bypass (RYGB) surgery and the remaining patients to the Intensive Medical Diabetes and Weight Management (IMWM).
The patients under the Medical Diabetes And Weight Management Program have participated in the exercise programs, changed the diet, took treatments (medications, pills or tablets) to increase the weight loss and participated in the educational classes. All of them are with high blood sugar levels (HbA1c levels between 7.2 and 9.8). Researchers assessed the following health parameters.
Researchers used the following tools in the study
The study shows the following.
This study shows even for a mild to a moderately obese patient with type 2 diabetes, the gastric bypass surgery can help in achieving sustained weight loss, lowers the risk of cardiovascular disease and HbA1c levels (improved diabetes management) compared with Medical Diabetes And Weight Management program. Medical diabetes and weight management program includes lifestyle modifications such as eating healthy foods with a low glycemic index, a regular exercise, avoiding alcohol/smoking and reducing stress.
Lead author of the study was Donald C. Simonson, MD, MPH, ScD, Lecturer in Medicine, Brigham and Women's Hospital, Boston, United States. Co-authors of the study were Allison B. Goldfine, Ashley Vernon, Florencia Halperin and Kathleen Foster. The study was published February 2018, in the Diabetes Care. Title of the article was "Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study."
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.